Siriwimon Saichaemchan - Academia.edu (original) (raw)

Uploads

Papers by Siriwimon Saichaemchan

Research paper thumbnail of Curcumin add-on improves quality of life in patients with locally or advanced head and neck cancer receiving nutritional intervention

Journal of clinical oncology, Jun 1, 2024

Research paper thumbnail of A double-blind, placebo-controlled randomized phase II study: Evaluating the effect of curcumin for treatment of cancer anorexia-cachexia syndrome in solid cancer patients

Journal of Clinical Oncology, May 20, 2019

Research paper thumbnail of Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy

Current Molecular Medicine, Jan 8, 2016

Research paper thumbnail of Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?

Research paper thumbnail of A Pilot Study of Using Smartphone Application vs. Routine Follow-Up for Patient Care in Advanced Non-Small Cell Lung Cancer During the COVID-19 Pandemic Era

Frontiers in Medical Technology

IntroductionCancer care monitoring should be adapted regarding COVID-19 pandemic preparedness pla... more IntroductionCancer care monitoring should be adapted regarding COVID-19 pandemic preparedness plans. Lung Cancer Care application was a mobile application program to monitor adverse events and report outcomes. This study is aimed to invent a new mobile application evaluating patient-reported outcome (PRO) for patients with non-small cell lung cancer (NSCLC) and to evaluate the validity of a mobile application, particularly during the COVID-19 pandemic era.MethodsThe validity of the application was tested, and Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaires were contained in the mobile application-based PRO. Patients were randomly assigned to use mobile application-based PRO vs. routine follow-up. The primary end point was to compare the quality of life (QoL) scores between two groups. A secondary end point was overall survival (OS) and the outcomes of progressive disease (PD) between the two groups.ResultsIn total, 33 patients with advanced NSCLC were enrolled. ...

Research paper thumbnail of Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia)

Journal of Nutrition and Metabolism

Background. Cancer anorexia-cachexia syndrome (CAS) is a significant comorbidity among all patien... more Background. Cancer anorexia-cachexia syndrome (CAS) is a significant comorbidity among all patients with cancer, increasing the mortality rate. Almost all patients with head and neck cancer experience this syndrome. CAS causes increased energy expenditure by increasing systemic inflammation and decreasing energy consumption due to anorexia. It leads to skeleton muscle breakdown and reduces the quality of life. Nutritional interventions and primary cancer treatment are the mainstays to manage this situation. However, a vicious cycle causes CAS to persist, especially in head and neck cancer, where tumour location and its treatment interfere with nutritional interventions. Curcumin shows anti-inflammatory effects, including modulated CAS in animal and in vitro studies. Objective. The study aimed to determine the effect of curcumin to treat cancer anorexia-cachexia syndrome among current patients with locally advanced or advanced head and neck cancer. Methods. This constitutes a randomi...

Research paper thumbnail of The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial

JCO Global Oncology

PURPOSE Nephrotoxicity is a major dose-limiting toxicity among patients with cancer who were trea... more PURPOSE Nephrotoxicity is a major dose-limiting toxicity among patients with cancer who were treated with cisplatin. Although no standard approach is available to prevent cisplatin-induced nephrotoxicity, administering intravenous isotonic saline is recommended. Additionally, mannitol combined with hydration has been evaluated, but none of them have been established. Our study aimed to determine the efficacy of mannitol combined hydration to prevent cisplatin-induced nephrotoxicity. PATIENTS AND METHODS This study was a phase II, randomized, placebo-controlled design. All patients with solid cancers who were treated with cisplatin (n = 48) were randomly assigned to receive either placebo (n = 25) or 20 g of mannitol (n = 23) after completing 2 L of prehydration and receiving cisplatin. Serum creatinine, blood urea nitrogen, electrolyte, and glomerular filtration rate (GFR) were measured at baseline and days 2 and 7. Moreover, GFR was calculated based on the 24-hour urine creatinine ...

Research paper thumbnail of Impact of Interprofessional Collaborative Practice in Palliative Care on Outcomes for Advanced Cancer Inpatients in Resource Limited Setting

Background Palliative care for advanced cancer patients improves suffering symptoms, quality of l... more Background Palliative care for advanced cancer patients improves suffering symptoms, quality of life (QoLs). However, routine implementation of palliative care by specialty palliative care consultation is still unmet need among advanced cancer inpatients. Our study aim is to evaluate the effectiveness of team-based approach on QoLs and readmission rate when compare to routine practice by among medical oncologists. Methods This study was prospective, Quasi-Experimental design. Advanced cancer inpatients were non-randomly assigned to receive palliative care service by team-based approach or medical oncologists only. The primary endpoint was QoL. The secondary endpoint was readmission rate at 7, and 30 days of hospital discharge. Results One hundred twenty-two inpatients were enrolled. Inpatients who were assessed by team-based approach had significantly improved in change scores of subjective well-being (SWB) when compare to another group (∆ SWB: -1 [-19–11] vs 0 [-9–15], p-value = 0....

Research paper thumbnail of Extremely high alpha-fetoprotein-producing adrenal hepatoid adenocarcinoma

BMJ Case Reports, 2021

Hepatoid adenocarcinoma (HAC) is a rare tumour that produces an alpha-fetoprotein (AFP) mimicking... more Hepatoid adenocarcinoma (HAC) is a rare tumour that produces an alpha-fetoprotein (AFP) mimicking hepatocellular carcinoma (HCC). Adrenal HAC is exceedingly rare. Here we report extremely high AFP-producing adrenal HAC, the first case in Thailand. A 47-year-old man presented with left flank pain and weight loss for 2 months. A palpably huge left flank mass was observed on physical examination. CT revealed a 7 cm enhanced mass involving the left adrenal gland and multiple contrast-enhanced hypodense masses in both liver lobes. The largest was a 3.7 cm at liver segment-VII without cirrhotic background, with an AFP level of 321 495 ng/mL. Both adrenal and liver biopsies were performed. This patient received a diagnosis of advanced adrenal HAC. Unfortunately, the tumour progressed, causing massive upper gastrointestinal bleeding and death. Adrenal HAC is challenging to diagnose, which multifocal HCC, pheochromocytoma and adrenocortical carcinoma should be excluded. Surgical resection is...

Research paper thumbnail of 1459P A comparative study on the effect of palliative care between palliative care team and medical oncologists in patients with advanced cancer at Phramongkutklao Hospital

Research paper thumbnail of 1679P A double-blind, placebo-controlled, randomized phase IIa trial, evaluating the effect of curcumin for the treatment of cancer anorexia-cachexia syndrome in patients with stage III-IV head and neck cancer (CurChexia)

Research paper thumbnail of A pilot study of using smartphone application versus routine follow up for patients' care in advanced non-small cell lung cancer (NSCLC)

Journal of Global Oncology, 2019

9 Background: Web-based patient reported outcome (PRO) improved quality of life (QoL), and overal... more 9 Background: Web-based patient reported outcome (PRO) improved quality of life (QoL), and overall survival (OS) in patients with advanced NSCLC who were treating with specific therapy. Lung Cancer Care application is a mobile application program that provides patients with individually tailored information on patient reported outcome. This study aims to invent a novel mobile application evaluating PRO for Thai NSCLC patients, and to evaluate the validity of mobile application. Methods: Our mobile application-based PRO was designed for monitoring quality of life. The validity of the application was tested following guidelines for translating, and validating a questionnaire. The quality of life score (FACT-L score). After the validated mobile application-based PRO, patients with advanced NSCLC were randomized to use mobile application-based PRO versus routine follow-up. The primary endpoint was quality of life (QoL). Secondary endpoint was OS. Results: Thirty-three patients with adva...

Research paper thumbnail of Kinase gene fusions in defined subsets of melanoma

Pigment Cell & Melanoma Research, 2017

SummaryGenomic rearrangements resulting in activating kinase fusions have been increasingly descr... more SummaryGenomic rearrangements resulting in activating kinase fusions have been increasingly described in a number of cancers including malignant melanoma, but their frequency in specific melanoma subtypes has not been reported. We used break‐apart fluorescence in situ hybridization (FISH) to identify genomic rearrangements in tissues from 59 patients with various types of malignant melanoma including acral lentiginous, mucosal, superficial spreading, and nodular. We identified four genomic rearrangements involving the genes BRAF, RET, and ROS1. Of these, three were confirmed by Immunohistochemistry (IHC) or sequencing and one was found to be an ARMC10‐BRAF fusion that has not been previously reported in melanoma. These fusions occurred in different subtypes of melanoma but all in tumors lacking known driver mutations. Our data suggest gene fusions are more common than previously thought and should be further explored particularly in melanomas lacking known driver mutations.

Research paper thumbnail of Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?

Research paper thumbnail of Curcumin add-on improves quality of life in patients with locally or advanced head and neck cancer receiving nutritional intervention

Journal of clinical oncology, Jun 1, 2024

Research paper thumbnail of A double-blind, placebo-controlled randomized phase II study: Evaluating the effect of curcumin for treatment of cancer anorexia-cachexia syndrome in solid cancer patients

Journal of Clinical Oncology, May 20, 2019

Research paper thumbnail of Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy

Current Molecular Medicine, Jan 8, 2016

Research paper thumbnail of Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?

Research paper thumbnail of A Pilot Study of Using Smartphone Application vs. Routine Follow-Up for Patient Care in Advanced Non-Small Cell Lung Cancer During the COVID-19 Pandemic Era

Frontiers in Medical Technology

IntroductionCancer care monitoring should be adapted regarding COVID-19 pandemic preparedness pla... more IntroductionCancer care monitoring should be adapted regarding COVID-19 pandemic preparedness plans. Lung Cancer Care application was a mobile application program to monitor adverse events and report outcomes. This study is aimed to invent a new mobile application evaluating patient-reported outcome (PRO) for patients with non-small cell lung cancer (NSCLC) and to evaluate the validity of a mobile application, particularly during the COVID-19 pandemic era.MethodsThe validity of the application was tested, and Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaires were contained in the mobile application-based PRO. Patients were randomly assigned to use mobile application-based PRO vs. routine follow-up. The primary end point was to compare the quality of life (QoL) scores between two groups. A secondary end point was overall survival (OS) and the outcomes of progressive disease (PD) between the two groups.ResultsIn total, 33 patients with advanced NSCLC were enrolled. ...

Research paper thumbnail of Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia)

Journal of Nutrition and Metabolism

Background. Cancer anorexia-cachexia syndrome (CAS) is a significant comorbidity among all patien... more Background. Cancer anorexia-cachexia syndrome (CAS) is a significant comorbidity among all patients with cancer, increasing the mortality rate. Almost all patients with head and neck cancer experience this syndrome. CAS causes increased energy expenditure by increasing systemic inflammation and decreasing energy consumption due to anorexia. It leads to skeleton muscle breakdown and reduces the quality of life. Nutritional interventions and primary cancer treatment are the mainstays to manage this situation. However, a vicious cycle causes CAS to persist, especially in head and neck cancer, where tumour location and its treatment interfere with nutritional interventions. Curcumin shows anti-inflammatory effects, including modulated CAS in animal and in vitro studies. Objective. The study aimed to determine the effect of curcumin to treat cancer anorexia-cachexia syndrome among current patients with locally advanced or advanced head and neck cancer. Methods. This constitutes a randomi...

Research paper thumbnail of The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial

JCO Global Oncology

PURPOSE Nephrotoxicity is a major dose-limiting toxicity among patients with cancer who were trea... more PURPOSE Nephrotoxicity is a major dose-limiting toxicity among patients with cancer who were treated with cisplatin. Although no standard approach is available to prevent cisplatin-induced nephrotoxicity, administering intravenous isotonic saline is recommended. Additionally, mannitol combined with hydration has been evaluated, but none of them have been established. Our study aimed to determine the efficacy of mannitol combined hydration to prevent cisplatin-induced nephrotoxicity. PATIENTS AND METHODS This study was a phase II, randomized, placebo-controlled design. All patients with solid cancers who were treated with cisplatin (n = 48) were randomly assigned to receive either placebo (n = 25) or 20 g of mannitol (n = 23) after completing 2 L of prehydration and receiving cisplatin. Serum creatinine, blood urea nitrogen, electrolyte, and glomerular filtration rate (GFR) were measured at baseline and days 2 and 7. Moreover, GFR was calculated based on the 24-hour urine creatinine ...

Research paper thumbnail of Impact of Interprofessional Collaborative Practice in Palliative Care on Outcomes for Advanced Cancer Inpatients in Resource Limited Setting

Background Palliative care for advanced cancer patients improves suffering symptoms, quality of l... more Background Palliative care for advanced cancer patients improves suffering symptoms, quality of life (QoLs). However, routine implementation of palliative care by specialty palliative care consultation is still unmet need among advanced cancer inpatients. Our study aim is to evaluate the effectiveness of team-based approach on QoLs and readmission rate when compare to routine practice by among medical oncologists. Methods This study was prospective, Quasi-Experimental design. Advanced cancer inpatients were non-randomly assigned to receive palliative care service by team-based approach or medical oncologists only. The primary endpoint was QoL. The secondary endpoint was readmission rate at 7, and 30 days of hospital discharge. Results One hundred twenty-two inpatients were enrolled. Inpatients who were assessed by team-based approach had significantly improved in change scores of subjective well-being (SWB) when compare to another group (∆ SWB: -1 [-19–11] vs 0 [-9–15], p-value = 0....

Research paper thumbnail of Extremely high alpha-fetoprotein-producing adrenal hepatoid adenocarcinoma

BMJ Case Reports, 2021

Hepatoid adenocarcinoma (HAC) is a rare tumour that produces an alpha-fetoprotein (AFP) mimicking... more Hepatoid adenocarcinoma (HAC) is a rare tumour that produces an alpha-fetoprotein (AFP) mimicking hepatocellular carcinoma (HCC). Adrenal HAC is exceedingly rare. Here we report extremely high AFP-producing adrenal HAC, the first case in Thailand. A 47-year-old man presented with left flank pain and weight loss for 2 months. A palpably huge left flank mass was observed on physical examination. CT revealed a 7 cm enhanced mass involving the left adrenal gland and multiple contrast-enhanced hypodense masses in both liver lobes. The largest was a 3.7 cm at liver segment-VII without cirrhotic background, with an AFP level of 321 495 ng/mL. Both adrenal and liver biopsies were performed. This patient received a diagnosis of advanced adrenal HAC. Unfortunately, the tumour progressed, causing massive upper gastrointestinal bleeding and death. Adrenal HAC is challenging to diagnose, which multifocal HCC, pheochromocytoma and adrenocortical carcinoma should be excluded. Surgical resection is...

Research paper thumbnail of 1459P A comparative study on the effect of palliative care between palliative care team and medical oncologists in patients with advanced cancer at Phramongkutklao Hospital

Research paper thumbnail of 1679P A double-blind, placebo-controlled, randomized phase IIa trial, evaluating the effect of curcumin for the treatment of cancer anorexia-cachexia syndrome in patients with stage III-IV head and neck cancer (CurChexia)

Research paper thumbnail of A pilot study of using smartphone application versus routine follow up for patients' care in advanced non-small cell lung cancer (NSCLC)

Journal of Global Oncology, 2019

9 Background: Web-based patient reported outcome (PRO) improved quality of life (QoL), and overal... more 9 Background: Web-based patient reported outcome (PRO) improved quality of life (QoL), and overall survival (OS) in patients with advanced NSCLC who were treating with specific therapy. Lung Cancer Care application is a mobile application program that provides patients with individually tailored information on patient reported outcome. This study aims to invent a novel mobile application evaluating PRO for Thai NSCLC patients, and to evaluate the validity of mobile application. Methods: Our mobile application-based PRO was designed for monitoring quality of life. The validity of the application was tested following guidelines for translating, and validating a questionnaire. The quality of life score (FACT-L score). After the validated mobile application-based PRO, patients with advanced NSCLC were randomized to use mobile application-based PRO versus routine follow-up. The primary endpoint was quality of life (QoL). Secondary endpoint was OS. Results: Thirty-three patients with adva...

Research paper thumbnail of Kinase gene fusions in defined subsets of melanoma

Pigment Cell & Melanoma Research, 2017

SummaryGenomic rearrangements resulting in activating kinase fusions have been increasingly descr... more SummaryGenomic rearrangements resulting in activating kinase fusions have been increasingly described in a number of cancers including malignant melanoma, but their frequency in specific melanoma subtypes has not been reported. We used break‐apart fluorescence in situ hybridization (FISH) to identify genomic rearrangements in tissues from 59 patients with various types of malignant melanoma including acral lentiginous, mucosal, superficial spreading, and nodular. We identified four genomic rearrangements involving the genes BRAF, RET, and ROS1. Of these, three were confirmed by Immunohistochemistry (IHC) or sequencing and one was found to be an ARMC10‐BRAF fusion that has not been previously reported in melanoma. These fusions occurred in different subtypes of melanoma but all in tumors lacking known driver mutations. Our data suggest gene fusions are more common than previously thought and should be further explored particularly in melanomas lacking known driver mutations.

Research paper thumbnail of Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?